🕵️ Carlsmed, Inc. ($CARL)
SEC insider & ownership activity, last 12 months · CIK 1794546 · every row links its SEC filing
Insider buy value was withheld pending verification over the last 12 months. No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, value withheld pending verification (1 lots) · 1 seller, $2.6M (1 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Cordonnier Michael | 0 | – | 1 | $2.6M | Mar 2, 2026 |
| Presidio Management Group XII, L.L.C. | 1 | value withheld pending verification | 0 | – | Jul 24, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| B Capital Group Management, L.P. | 27.8% | 13G | Nov 14, 2025 | filing ↗ | |
| Casey M. Tansey | 22.0% | 13G | Nov 13, 2025 | filing ↗ | |
| Presidio Management Group XII, L.L.C. | 21.2% | 13G | Nov 13, 2025 | filing ↗ | |
| B Capital Global Growth III, L.P. | 18.9% | 13G | Nov 14, 2025 | filing ↗ | |
| U.S. Venture Partners XII, L.P. | 16.2% | 13G | Nov 13, 2025 | filing ↗ | |
| B Capital Healthcare I, L.P. | 8.9% | 13G | Nov 14, 2025 | filing ↗ | |
| Michael Cordonnier | 5.9% | 13G | Jul 24, 2025 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Cordonnier Michael | $2.6M | Mar 2, 2026 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Sep 4, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Sep 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 4, 2026 | filing ↗ |
| Earnings (2.02) | Aug 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 5, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 3, 2026 | filing ↗ |
| Earnings (2.02) | May 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 5, 2026 | filing ↗ |
| Earnings (2.02) | Feb 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 25, 2026 | filing ↗ |
| Earnings (2.02) | Jan 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 12, 2026 | filing ↗ |
| Earnings (2.02) | Nov 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing ↗ |
| Material agreement (1.01) | Oct 29, 2025 | filing ↗ |
| New financial obligation (2.03) | Oct 29, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 29, 2025 | filing ↗ |